Abstract

Because lung transplant recipients are at high risk for invasive aspergillosis (IA), many centers employ the antifungal medication voriconazole as

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call